Reimbursement of Patent Expenses. Licensee will reimburse UM’s future Patent Expenses incurred after the Effective Date of this Agreement within forty-five (45) days of receipt of an invoice from UM detailing the Patent Expenses incurred by UM.
Reimbursement of Patent Expenses. AMT shall reimburse ST. JUDE for all out of pocket patent-related expenses incurred by ST. JUDE pursuant to Section 6.1 related to Patent Rights during the term of this Agreement within [**] days after ST. JUDE invoices AMT subject to the provisions of this Section. Such invoice shall contain a breakdown of the expenses and be accompanied by supporting evidence of such expenses as appropriate including copies of invoices from external patent counsel. ST JUDE shall instruct its patent counsel to communicate with AMT directly on all matters pertaining to the activities of patent counsel, including the giving of forward cost estimates, but copying ST JUDE on all e-mails and other correspondence.
6.2.1 If ST. JUDE grants an exclusive license under the Patent Rights outside of the Field, ST. JUDE shall promptly notify AMT. In such an event, from the effective date of that license, AMT shall be responsible for [**] percent ([**]%) of the patent-related expenses only.
Reimbursement of Patent Expenses. Licensee shall reimburse Penn for all documented attorneys fees, expenses, official fees and other charges incurred prior to the Effective Date and incident to the preparation, prosecution and maintenance of Penn Patent Rights. This reimbursement obligation shall be paid as follows:
6.2.1 twenty five thousand dollars ($25,000) or the balance due, whichever is less, to be paid within ten (10) days of the date that Licensee first raises three hundred thousand dollars ($300,000) in equity investment after the Effective Date, but in any event not later than May 31, 2003.
6.2.2 forty thousand dollars ($40,000) or the balance due, whichever is less, to be paid within ten (10) days after Licensee first raises a total of three million dollars ($3,000,000) in equity investment after the Effective Date, but in any event not later than May 31, 2003.
6.2.3 forty thousand dollars ($40,000) or the balance due, whichever is less, ninety (90) days after the date on which the payment under Section 6.2.2 is due and payable.
6.2.4 The balance shall be paid within ninety (90) days after the date that the payment under Section 6.2.3 is due and payable.
Reimbursement of Patent Expenses. UM’s out-of-pocket Patent Expenses incurred before the Effective Date of this Agreement (“Sunk Patent Expenses”) are to be paid by Licensee by within forty-five (45) days of receipt of an invoice from UM detailing the Sunk Patent Expenses incurred by UM. In addition, Licensee will reimburse UM’s future Patent Expenses incurred after the Effective Date of this Agreement within forty-five (45) days of receipt of an invoice from UM detailing the Patent Expenses incurred by UM.
Reimbursement of Patent Expenses. Nalu shall be solely responsible for Prosecution and Maintenance expenses for the AcceleMed Assigned Patents, AcceleMed Licensed Patents and AcceleMed Improvement Patents, provided AcceleMed agrees to reimburse Nalu for the expenses incurred by Nalu with respect to Prosecution and Maintenance of AcceleMed Continuations, solely to the extent such Prosecution and Maintenance has been requested by AcceleMed.
Reimbursement of Patent Expenses. Within [**] days after the end of each calendar quarter, TherapX shall provide Novirio with an invoiced accounting of all patent related expenses incurred by TherapX, as described in Section 4.1, below, during such calendar quarter. Novirio shall reimburse TherapX for all such invoiced patent related expenses [**] after receipt of such accounting.
Reimbursement of Patent Expenses. UM's out-of-pocket Patent Expenses incurred before the Effective Date of this Agreement ("Sunk Patent Expenses") are to be paid by Licensee under the License Agreement executed by the parties for delivery of amino acid esters to the oral cavity ("Oral Cavity License Agreement"). Should the Oral Cavity License Agreement be terminated for any reason before payment of UM's Sunk Patent Expenses, Licensee shall reimburse UM's Sunk Patent Expenses under this Agreement by February 15, 2015. In addition, Licensee will reimburse UM's future Patent Expenses incurred after the Effective Date of this Agreement that have not been paid under the terms of the Oral Cavity License Agreement within forty-five (45) days of receipt of an invoice from UM detailing the Patent Expenses incurred by UM.
Reimbursement of Patent Expenses. Rigel will reimburse Questcor for all of Questcor's expenses associated with preparing, maintaining, prosecuting, enforcing and defending the Questcor Patents that Questcor incurred prior to the Effective Date. Rigel will also reimburse Questcor for the patent expenses paid by Questcor under the Washington License Agreement that Questcor incurred prior to the effective date of such assignment (or exclusive sublicense). Rigel will pay Questcor under this section within thirty (30) days after receiving an itemized accounting of each set of prior patent expenses. The total amount reimbursed to Questcor under this Section 6.4 shall not exceed $250,000.
Reimbursement of Patent Expenses. During the term of the Agreement, Licensee shall be responsible for reasonable expenses incurred with respect to the Patent Rights in connection with the activities set forth in Section 9.1 above. Licensee may credit such amounts against royalties due Licensor pursuant to Article 3.
Reimbursement of Patent Expenses. Schedule 5.2 sets forth a list of all out-of-pocket expenses incurred by Licensor as of the Effective Date in connection with the preparation, filing, Prosecution, and maintenance of the Licensor Patent Rights in [*], including all fees and other amounts paid to any Patent Office in such countries. No later than [*] after receipt of a written invoice from Licensor on or after the Effective Date, Licensee will pay to Licensor a one-time payment of all amounts set forth on Schedule 5.2 in cash in immediately available funds by wire transfer, in accordance with wire instructions to be given by Licensor to Licensee.
